Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3QQU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,998
Award facts
- Contract value 100% obligated
- $13,997.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,997.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 5, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026, which serves as the comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical procurement ecosystem. The company's extensive portfolio of federal contracts demonstrates its capability to supply diverse pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's planned Pharmaceutical Prime Vendor Global Program Generation V contracts, intended for multiple regional awards, reflect the strategic approach to pharmaceutical supply chain management for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3QQU?
SPE2DR26F3QQU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F3QQU worth?
The government has obligated $13,998 on SPE2DR26F3QQU.
Is contract SPE2DR26F3QQU an order under another contract?
Yes. SPE2DR26F3QQU is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QQU competed?
The extent of competition for SPE2DR26F3QQU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award